Scholars Central

OtherPublished 27 Jul 2016

Novel, single-dose microsphere formulation of azithromycin extendedrelease for the treatment of respiratory tract infections

Authors: Maya Tatum, Guy W Amsden

Clinical Practice

Volume 3 · Issue 3 · Pages 357

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This paper reviews the pharmacology, efficacy and safety of the new single-dose azithromycin 2 g extended-release microsphere formulation that has been approved in various countries for the treatment of a variety of upper and lower community-acquired respiratory tract infections. As it has been demonstrated to be at least as effective and safe as valid, contemporary comparators, this new single-dose formulation of azithromycin offers the first treatment option for respiratory tract infections that lends itself to 100% patient compliance and regimen completion.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Practice.

All its articles

Article · 28 Mar 2025

Using

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Maya Tatum”
  • BylineArticles whose byline prints “Guy W Amsden”